Recent 8-K filings for BG

• April 29, 2026, 7:59 PM ET earnings materiality 0.80 positive item 2.02item 9.01 ◈ Earnings Releases

  Bunge Q1 adjusted EPS $1.83 beats prior year; raises FY outlook to $9.00-9.50

  Q1 GAAP diluted EPS $0.35 vs $1.48 prior year; adjusted EPS $1.83 vs $1.81.

• April 1, 2026, 7:59 PM ET other material materiality 0.60 neutral item 5.02item 9.01

  Bunge Global SA grants PBRSUs to execs tied to Viterra integration synergy targets

  CEO Gregory Heckman receives 63,281 PBRSUs; CFO John Neppl receives 12,099; COO Garros 19,501.

• March 17, 2026, 7:59 PM ET other material materiality 0.60 neutral item 8.01item 9.01

  Bunge files Viterra H1 2025 financials; Viterra reports $199M net loss on $20.97B revenue

  Viterra H1 2025 revenue $20,974M (down 7% YoY from $22,572M); net loss $199M vs income $70M.

• February 4, 2026, 6:59 PM ET earnings materiality 0.75 negative item 2.02item 9.01

  Bunge FY2025 GAAP EPS $4.93 (down 38%); Q4 adjusted EPS $1.99 near prior $2.13

  Full-year GAAP diluted EPS $4.93 vs $7.99; adjusted $7.57 vs $9.19.

• December 12, 2025, 6:59 PM ET leadership materiality 0.60 neutral item 5.02item 9.01

  Bunge Global SA COO David Mattiske steps down; Julio Garros becomes sole COO effective Dec 12, 2025

  David Mattiske resigns as co-Chief Operating Officer effective Dec 11, 2025, to pursue other professional opportunities.

• November 5, 2025, 6:59 PM ET earnings materiality 0.70 neutral item 2.02item 9.01

  Bunge Q3 adjusted EPS $2.27 vs $2.29 YoY, repurchases $545M shares, reaffirms FY guidance $7.30-$7.60

  Q3 GAAP diluted EPS $0.86 vs $1.56 YoY; adjusted EPS $2.27 vs $2.29.

• October 15, 2025, 7:59 PM ET other material materiality 0.60 neutral item 7.01item 9.01

  Bunge changes segment reporting and recasts 2025 outlook after Viterra combination

  Oilseeds realigned into Soybean Processing and Refining, Softseed Processing and Refining, and Other Oilseeds Processing and Refining.

• July 30, 2025, 7:59 PM ET earnings materiality 0.75 neutral item 2.02item 9.01

  Bunge Q2 GAAP EPS $2.61, adjusted $1.31; merger with Viterra completed

  GAAP diluted EPS $2.61 vs $0.48 prior year; net income $354M vs $70M.

• July 7, 2025, 7:59 PM ET other material materiality 0.75 positive item 8.01item 9.01

  Bunge completes Viterra acquisition; exchange offers expire, settlement July 8

  Business combination with Viterra closed on July 2, 2025.

• July 2, 2025, 7:59 PM ET M&A materiality 1.00 positive item 2.01item 1.01item 5.02item 7.01item 9.01 ◈ M&A Transactions

  Bunge completes merger with Viterra, creating global agribusiness solutions company

  Bunge acquired all outstanding Viterra shares, issuing 65.6M shares valued at ~$5.3B plus $2B cash to Sellers.

• June 30, 2025, 7:59 PM ET debt materiality 0.75 neutral item 1.01item 2.03item 9.01 ◈ Debt Financings

  Bunge borrows $2B via term loan to fund Viterra acquisition; matures 2028

  BLFC enters $2B term loan agreement with Sumitomo Mitsui Banking Corp as administrative agent; matures June 1, 2028.

• June 13, 2025, 7:59 PM ET M&A materiality 0.90 neutral item 1.01item 7.01item 9.01

  Bunge-Viterra merger closing set for July 2, 2025; Chinese, Mexican antitrust approvals received

  Closing date mutually agreed as July 2, 2025, subject to satisfaction of remaining conditions.

• June 12, 2025, 7:59 PM ET debt materiality 0.60 neutral item 8.01item 9.01

  Bunge extends Viterra note exchange offer to July 3, 2025, pending acquisition close

  Expiration date extended from June 13 to July 3, 2025, for exchange of up to $1.95B in Viterra notes.

• May 7, 2025, 7:59 PM ET earnings materiality 0.75 neutral item 2.02item 9.01

  Bunge Q1 adj EPS $1.81 vs $3.04 YoY; maintains FY guidance ~$7.75

  GAAP diluted EPS $1.48 vs $1.68 prior year; adjusted EPS $1.81 vs $3.04.

• February 5, 2025, 6:59 PM ET earnings materiality 0.75 negative item 2.02item 9.01

  Bunge FY2024 adjusted EPS $9.19 vs $13.66; Q4 adjusted EPS $2.13 vs $3.70

  Full-year GAAP diluted EPS $7.99 (2023: $14.87); adjusted EPS $9.19 vs $13.66.

• November 15, 2024, 6:59 PM ET other material materiality 0.70 positive item 8.01item 9.01

  Bunge expands share repurchase program with additional $500M authorization to ~$1.3B total

  Board authorized an additional $500M in share repurchases on November 13, 2024.

• October 30, 2024, 7:59 PM ET M&A materiality 0.65 positive item 8.01item 9.01

  Bunge extends Viterra note exchange offers to Jan 2, 2025; 94-99% tendered

  Exchange offer expiration extended from Oct 31, 2024 to Jan 2, 2025; all terms unchanged.

• October 30, 2024, 7:59 PM ET earnings materiality 0.75 negative item 2.02item 9.01

  Bunge Q3 adjusted EPS $2.29 vs $2.99 YoY; full-year guidance at least $9.25

  Q3 GAAP diluted EPS $1.56 vs $2.47; adjusted EPS $2.29 vs $2.99 in prior year.

• October 7, 2024, 7:59 PM ET debt materiality 0.60 neutral item 8.01item 9.01

  Bunge extends Viterra note exchange offers to Oct 31; tender rates high

  BLFC extends expiration date from Oct 7 to 5:00 p.m. NY time on Oct 31, 2024.

• October 1, 2024, 7:59 PM ET M&A materiality 0.75 positive item 8.01item 9.01

  Bunge sells 50% stake in BP Bunge Bioenergia JV for ~$828M net

  Sold 50% ownership in BP Bunge Bioenergia (sugar/ethanol JV) to BP affiliate for approx. $828M net.

• September 11, 2024, 7:59 PM ET debt materiality 0.60 neutral item 8.01item 9.01

  Bunge prices $2.0B senior notes offering in three tranches to fund Viterra acquisition

  $400M 4.100% notes due 2028, $800M 4.200% notes due 2029, $800M 4.650% notes due 2034.

• September 9, 2024, 7:59 PM ET M&A materiality 0.75 negative item 8.01item 9.01

  Bunge files Viterra FY2023 financials: revenue $54.7B, net income $453M (down 56% YoY)

  Viterra 2023 revenue $54,673M; net income $453M vs $1,042M in 2022; gross margin $1,702M.

• September 9, 2024, 7:59 PM ET debt materiality 0.75 neutral item 8.01item 9.01

  Bunge subsidiary launches up to $1.95B exchange offer for Viterra notes pending acquisition

  BLFC offers to exchange all Viterra notes (2026/2027/2031/2032) for new Bunge-guaranteed notes plus $1 cash per $1,000.

• July 31, 2024, 7:59 PM ET earnings materiality 0.85 negative item 2.02item 9.01

  Bunge Q2 adjusted EPS $1.73 vs $3.72; GAAP EPS $0.48; cuts FY outlook to ~$9.25

  Q2 GAAP diluted EPS $0.48 (down 88% vs $4.09); adjusted EPS $1.73 (down 54% vs $3.72).

• June 24, 2024, 7:59 PM ET M&A materiality 0.70 neutral item 8.01item 9.01

  Bunge to sell 50% stake in BP Bunge Bioenergia JV for ~$800M

  Bunge will sell its 50% interest in the BP Bunge Bioenergia JV to BP for an estimated net $800M.

• April 24, 2024, 7:59 PM ET earnings materiality 0.70 neutral item 2.02item 9.01 ◈ Earnings Releases

  Bunge Q1 GAAP EPS $1.68 down 59% YoY; adj EPS $3.04; maintains FY ~$9 outlook

  Q1 GAAP diluted EPS $1.68 vs $4.15 prior year; net income $244M down from $632M.

Earnings & guidance

Materiality & sentiment trend

Max materiality 1.00 · Median 0.60 · Most common event debt

7 positive 5 negative 35 neutral

source · BG on sec.gov